Market Research Logo

European Product Portfolio for Urological Devices 2016 - MedFolio

European Product Portfolio for Urological Devices 2016 - MedFolio

Although a highly commoditized market, an increasing global awareness of infection rates is helping to drive a single-use device preference. This results in higher unit sales and an associated growth in market value. Despite this preference, there is an ongoing push within the U.K. to gain acceptance of reusable catheters. The shift within urological endoscopes from fiber devices to video devices is not complete and therefore the urological endoscope market should continue to exhibit strong growth for the near future. Additionally, the urinary catheter market is expected to exhibit strong growth, particularly hydrophilic catheters.

The European urology market includes the segments for TURP devices, laser BPH devices, brachytherapy, urinary catheters, nephrostomy devices, urinary incontinence slings, stone treatment devices, urological endoscopes and erectile dysfunction devices. As a whole the urological device market is very well established. This limits potential for substantial growth. Although companies continue to provide novel adaptations to their products, the general trend within the market is a slightly declining ASP. However, some segments are an exception to this – lasers (for both BPH and stone management) have recently seen some exciting developments.


LIST OF FIGURES
LIST OF CHARTS
EXECUTIVE SUMMARY
EUROPEAN UROLOGICAL DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
MARKETS INCLUDED
PROCEDURES INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
PRODUCT ASSESSMENT
2.1 PRODUCT PORTFOLIOS
2.1.1 Urinary Catheters
2.1.1.1 Intermittent Catheters
2.1.1.2 Foley Catheters
2.1.1.2.1 Male External Catheters
2.1.1.3 Urethral Bulking Agent
2.1.2 Female Incontinence Sling
2.1.3 Male Incontinence Sling
2.1.4 Stone Management
2.1.5 TURP
2.1.6 BPH Treatment
2.1.6.1.1 TUMT
2.1.6.1.2 TUNA
2.1.6.1.3 Prostatic Stent
2.1.7 Urologoical Endoscope
2.1.7.1.1 Cystoscope
2.1.7.1.2 Ureteroscope
2.1.7.1.3 Resectoscope
2.1.7.1.4 Nephroscope
2.1.8 Brachytherapy
2.1.8.1.1 HDR
2.1.8.1.2 LDR
2.1.9 Nephrostomy
2.1.10 ED
2.2 REGULATORY ISSUES AND RECALLS
2.2.1 Urinary Catheters
2.2.2 Urinary Intermittent Catheters
2.2.3 Urinary Foley Catheters
2.2.4 Urinary Balloon Catheters
2.2.5 Female Incontinence Sling
2.2.6 Erectile Dysfunction
2.3 CLINICAL TRIALS
2.3.1 Boston Scientific
2.3.2 C.R. Bard
2.3.3 Coloplast
2.3.4 Dornier MedTech
2.3.5 Ethicon
2.3.6 GE (Oncura)
2.3.7 Hollister
2.3.8 Lumenis
2.3.9 Olympus
2.3.10 Teleflex
2.3.11 WellSpect Healthcare
ABBREVIATIONS
APPENDIX II: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Total Urological Device Market, Europe, 2012 – 2022
Chart 1 2: Total Urological Device Market Overview, Europe, 2015 & 2022
List of Figures
Figure 1 1: Urological Device Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 2)
Figure 1 2: Urological Device Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 2)
Figure 1 3: Companies Mentioned in Report
Figure 1 4: Factors Impacting the Urological Device Market by Segment, Europe (1 of 2)
Figure 1 5: Factors Impacting the Urological Device Market by Segment, Europe (2 of 2)
Figure 1 6: Recent Events in Urological Device Market, Europe, 2012 – 2016
Figure 1 7: Urological Device Markets Covered, Europe, 2015, (Part 1 of 2)
Figure 1 8: Urological Device Markets Covered, Europe, 2015, (Part 2 of 2)
Figure 1 9: Urological Procedures Covered, Europe, 2015
Figure 1 10: Key Report Updates
Figure 1 11: Version History
Figure 2 1: Urinary Catheter Products by Company
Figure 2 2: Male External Catheters Products by Company
Figure 2 3: Incontinence Sling Products by Company
Figure 2 4: Stone Management Products by Company
Figure 2 5: BPH Treatment Products by Company
Figure 2 6: Urological Endoscope Products by Company
Figure 2 7: Nephrostomy Products by Company
Figure 2 8: ED Products by Company
Figure 2 9: Class 2 Device Recall Coloplast
Figure 2 10: Class 2 Device Recall Coloplast
Figure 2 11: Class 2 Device Recall Medtronic (Covidien)
Figure 2 12: Class 3 Device Recall C.R. Bard
Figure 2 13: Class 2 Device Recall Covidien
Figure 2 14: Class 2 Device Recall Boston Scientific
Figure 2 15: Class 2 Device Recall C.R. Bard
Figure 2 16: Class 2 Device Recall C.R. Bard
Figure 2 17: Class 2 Device Recall C.R. Bard
Figure 2 18: Class 2 Device Recall Covidien
Figure 2 19: Class 3 Device Recall C.R. Bard
Figure 2 20: Class 2 Device Recall Cook Medical
Figure 2 21: Class 2 Device Recall Covidien
Figure 2 22: Class 2 Device Recall Ethicon
Figure 2 23: Class 2 Device Recall Medtronic Vascular
Figure 2 24: Class 2 Device Boston Scientific
Figure 2 25: Class 2 Device Recall Astora
Figure 2 26: Class 2 Device Recall Coloplast
Figure 2 27: Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME)
Figure 2 28: Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology (PINNACLE FLX)
Figure 2 29: Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy (MIRACLEIII)
Figure 2 30: Watchman FLX Left Atrial Appendage Closure Device Post Approval Study
Figure 2 31: Expanding MRI Access for Patients With New and Existing ICDs and CRT-Ds ( ENABLE MRI) (ENABLE MRI)
Figure 2 32: Observation of ImageReady™ MR Conditional Pacing System in China
Figure 2 33: EVOLVE Short DAPT Study
Figure 2 34: ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent (IMPERIAL)
Figure 2 35: CoverEdge Algorithm Programming Study
Figure 2 36: Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
Figure 2 37: The Captivator EMR Registry
Figure 2 38: FAST Feasibility Study
Figure 2 39: Using the Vessix Renal Denervation System for the Treatment of Hypertension
Figure 2 40: A Study to Evaluate the Effect of Precision Spectra™ Programming
Figure 2 41: Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
Figure 2 42: Study of Phasix™ Mesh for VHWG Grade 3 Midline Hernia Repair
Figure 2 43: A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon
Figure 2 44: Korean Post-market Registry Assessing the Clinical Use and Safety of the Lutonix
Figure 2 45: A Prospective Trial of a Bio-absorbable Mesh
Figure 2 46: A Post-Market, Single-Arm Trial of XenMatrix™ AB Surgical Graft
Figure 2 47: BARD® The VENOVO™ Venous Stent Study
Figure 2 48: Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft (AVeNEW)
Figure 2 49: Time and Motion Related to PICC Insertion Process and Catheter Tip Confirmation
Figure 2 50: Prospective Feasibility Trial of AccuCath 2.25 BC
Figure 2 51: Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment
Figure 2 52: Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
Figure 2 53: Investigation of Two New 1-piece Ostomy Products
Figure 2 54: Investigation of a New 2-piece Ostomy Product
Figure 2 55: Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence
Figure 2 56: ARIES for Vasculogenic Erectile Dysfunction
Figure 2 57: The EVICEL® Neurosurgery Phase III Study
Figure 2 58: Powered Surgical Stapler in VATS Lung Resection Procedures in China
Figure 2 59: Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit
Figure 2 60: Clinical Evaluation of a Dual Energy CT System
Figure 2 61: Assessment of a Oral Endotracheal Tube Fastener
Figure 2 62: Utilizing Holmium Laser for FURS Renal Stone Lithotripsy
Figure 2 63: Ablation Efficacy of Contact Side Firing Fiber in Predefined Settings for Treating BPH.
Figure 2 64: Feasibility of IPL for Reducing Dry Eye Symptoms Caused by MGD
Figure 2 65: Radiofrequency Ablation for Multi-level Obstructive Sleep Apnea
Figure 2 66: Evaluation and Control of WAG in PACU Within Patient and Caregiver Breathing Zone
Figure 2 67: Evaluation of a Novel Electronic Transanal Irrigation System - Navina™ Smart
Figure 4 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report